Don't let it get away!
Keep track of the stocks that matter to you.
Help yourself with the Fool's FREE and easy new watchlist service today.
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.
What: Shares of home beverage carbonation system specialist SodaStream International (Nasdaq: SODA ) climbed as high as 16% in early Wednesday trading after its quarterly results and guidance topped Wall Street expectations.
So what: SodaStream's third-quarter results were so strong -- earnings surged to 7.8 million euros from 2.1 million euros in the year-ago period, while revenue jumped 39% -- that investors quickly jumped on the chance to ride the operating momentum. Unfortunately, overall market concerns surrounding Italy's debt crisis are proving just too powerful, with SodaStream shares now up only 2% at the time of this writing.
Now what: Looking ahead, management now expects revenue growth of 36% for the full year, versus its previous 30% forecast. "As we approach the holiday season in the U.S., we will leverage our increased distribution, along with heightened brand awareness, allocating greater resources to penetrate additional households and capitalize on this large market opportunity," said CEO Daniel Birnbaum. SodaStream remains a questionable long-term investment for many Fools, but given the strong results and positive near-term outlook, today's European panic might be providing investors with a tasty trading opportunity.
Interested in more info on SodaStream? Add it to your watchlist.
RSS Headlines
Fool UK
Comments from our Foolish Readers
Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the
Report this Comment icon found on every comment.
Be the first one to comment on this article.